Observational studyMedicine2025

Results in chronic hepatitis B patients using tenofovir and entecavir for at least 10 years; HBV clearance rare, disease outcomes good: An observational cohort study.

Zülal İstemihan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.